CAR T cells for treating autoimmune diseases
Autoimmune disorders occur when immune cells go wrong and attack the body’s own tissues. Currently, autoimmune disorders are largely treated by broad immunosuppressive agents and blocking antibodies, which can manage the diseases but often are not curative. Thus, there is an urgent need for advanced...
Saved in:
Main Authors: | Dimitrios Mougiakakos, Ulrike Koehl, Stephan Fricke, Ulrich Blache, Sandy Tretbar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/4/e002907.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
by: Yurou Chu, et al.
Published: (2025-02-01) -
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01) -
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
by: Rossana Di Staso, et al.
Published: (2024-11-01) -
The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases
by: Mariana Reste, et al.
Published: (2024-10-01) -
Corrigendum: The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases
by: Mariana Reste, et al.
Published: (2025-02-01)